Evaluating Medicinal Plants for Anticancer Activity

Plants have been used for medical purposes since the beginning of human history and are the basis of modern medicine. Most chemotherapeutic drugs for cancer treatment are molecules identified and isolated from plants or their synthetic derivatives. Our hypothesis was that whole plant extracts select...

Full description

Saved in:
Bibliographic Details
Main Authors: Elisha Solowey, Michal Lichtenstein, Sarah Sallon, Helena Paavilainen, Elaine Solowey, Haya Lorberboum-Galski
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2014/721402
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549132254838784
author Elisha Solowey
Michal Lichtenstein
Sarah Sallon
Helena Paavilainen
Elaine Solowey
Haya Lorberboum-Galski
author_facet Elisha Solowey
Michal Lichtenstein
Sarah Sallon
Helena Paavilainen
Elaine Solowey
Haya Lorberboum-Galski
author_sort Elisha Solowey
collection DOAJ
description Plants have been used for medical purposes since the beginning of human history and are the basis of modern medicine. Most chemotherapeutic drugs for cancer treatment are molecules identified and isolated from plants or their synthetic derivatives. Our hypothesis was that whole plant extracts selected according to ethnobotanical sources of historical use might contain multiple molecules with antitumor activities that could be very effective in killing human cancer cells. This study examined the effects of three whole plant extracts (ethanol extraction) on human tumor cells. The extracts were from Urtica membranacea (Urticaceae), Artemesia monosperma (Asteraceae), and Origanum dayi post (Labiatae). All three plant extracts exhibited dose- and time-dependent killing capabilities in various human derived tumor cell lines and primary cultures established from patients’ biopsies. The killing activity was specific toward tumor cells, as the plant extracts had no effect on primary cultures of healthy human cells. Cell death caused by the whole plant extracts is via apoptosis. Plant extract 5 (Urtica membranacea) showed particularly strong anticancer capabilities since it inhibited actual tumor progression in a breast adenocarcinoma mouse model. Our results suggest that whole plant extracts are promising anticancer reagents.
format Article
id doaj-art-ec917ba5503448e39d3a5a2585bbdd75
institution Kabale University
issn 2356-6140
1537-744X
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-ec917ba5503448e39d3a5a2585bbdd752025-02-03T06:12:07ZengWileyThe Scientific World Journal2356-61401537-744X2014-01-01201410.1155/2014/721402721402Evaluating Medicinal Plants for Anticancer ActivityElisha Solowey0Michal Lichtenstein1Sarah Sallon2Helena Paavilainen3Elaine Solowey4Haya Lorberboum-Galski5Department of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada (IMRIC), Hebrew University Hadassah Medical School, 91120 Jerusalem, IsraelDepartment of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada (IMRIC), Hebrew University Hadassah Medical School, 91120 Jerusalem, IsraelLouis L. Borick Natural Medicine Research Center, Hadassah Medical Organization, 91120 Jerusalem, IsraelLouis L. Borick Natural Medicine Research Center, Hadassah Medical Organization, 91120 Jerusalem, IsraelArava Institute of Environmental Studies, Kibbutz Ketura, 88840 DN Eilot, IsraelDepartment of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada (IMRIC), Hebrew University Hadassah Medical School, 91120 Jerusalem, IsraelPlants have been used for medical purposes since the beginning of human history and are the basis of modern medicine. Most chemotherapeutic drugs for cancer treatment are molecules identified and isolated from plants or their synthetic derivatives. Our hypothesis was that whole plant extracts selected according to ethnobotanical sources of historical use might contain multiple molecules with antitumor activities that could be very effective in killing human cancer cells. This study examined the effects of three whole plant extracts (ethanol extraction) on human tumor cells. The extracts were from Urtica membranacea (Urticaceae), Artemesia monosperma (Asteraceae), and Origanum dayi post (Labiatae). All three plant extracts exhibited dose- and time-dependent killing capabilities in various human derived tumor cell lines and primary cultures established from patients’ biopsies. The killing activity was specific toward tumor cells, as the plant extracts had no effect on primary cultures of healthy human cells. Cell death caused by the whole plant extracts is via apoptosis. Plant extract 5 (Urtica membranacea) showed particularly strong anticancer capabilities since it inhibited actual tumor progression in a breast adenocarcinoma mouse model. Our results suggest that whole plant extracts are promising anticancer reagents.http://dx.doi.org/10.1155/2014/721402
spellingShingle Elisha Solowey
Michal Lichtenstein
Sarah Sallon
Helena Paavilainen
Elaine Solowey
Haya Lorberboum-Galski
Evaluating Medicinal Plants for Anticancer Activity
The Scientific World Journal
title Evaluating Medicinal Plants for Anticancer Activity
title_full Evaluating Medicinal Plants for Anticancer Activity
title_fullStr Evaluating Medicinal Plants for Anticancer Activity
title_full_unstemmed Evaluating Medicinal Plants for Anticancer Activity
title_short Evaluating Medicinal Plants for Anticancer Activity
title_sort evaluating medicinal plants for anticancer activity
url http://dx.doi.org/10.1155/2014/721402
work_keys_str_mv AT elishasolowey evaluatingmedicinalplantsforanticanceractivity
AT michallichtenstein evaluatingmedicinalplantsforanticanceractivity
AT sarahsallon evaluatingmedicinalplantsforanticanceractivity
AT helenapaavilainen evaluatingmedicinalplantsforanticanceractivity
AT elainesolowey evaluatingmedicinalplantsforanticanceractivity
AT hayalorberboumgalski evaluatingmedicinalplantsforanticanceractivity